Home Life Sciences Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles
Article
Licensed
Unlicensed Requires Authentication

Hypoxia-inducible factor prolyl 4-hydroxylases: common and specific roles

  • Johanna Myllyharju

    Johanna Myllyharju is Professor of Molecular Biology and the Scientific Director of Biocenter Oulu, University of Oulu. Her research focuses on the key enzymes involved in the regulation of collagen synthesis and hypoxia response. She is a Member of the Academy of Finland Health Sciences Council and a Member of the Management Committee of the EU COST Action TD0901 HypoxiaNet.

    EMAIL logo
    and Peppi Koivunen

    Peppi Koivunen is Professor of Medical Biochemistry in the University of Oulu, Finland. Her research focus is 2-oxoglutaratedependent dioxy genases, such as the HIF prolyl 4-hydroxylases, the HIF asparaginyl hydroxylase FIH and a novel transmembrane prolyl 4-hydroxylase, P4H-TM. Koivunen also studies the role of 2-oxoglutarate analogues in cancer, erythropoiesis, ischemia and metabolism.

Published/Copyright: February 28, 2013

Abstract

Hypoxia-inducible transcription factor (HIF), an αβ dimer, is the key inducer of hypoxia-responsive genes that operate both during normal development and pathological processes in association with decreased oxygen availability. The products of HIF target genes function in, e.g., hematopoiesis, angiogenesis, iron transport, glucose utilization, resistance to oxidative stress, cell proliferation, survival and apoptosis, extracellular matrix homeostasis, and tumorigenesis and metastasis. HIF is accumulated in hypoxia, whereas it is rapidly degraded in normoxic cells. The oxygen-sensing mechanism behind this phenomenon is provided by HIF prolyl 4-hydroxylases (HIF-P4Hs, commonly known as PHDs and EglNs) that require oxygen in their reaction. In normoxia, two prolines in the oxygen-dependent degradation domain of the HIFα subunit become hydroxylated by the HIF-P4Hs. The 4-hydroxyproline residues formed serve as recognition sites for the von Hippel-Lindau E3 ubiquitin ligase complex and result in subsequent ubiquitination and instant proteasomal degradation of HIFα in normoxia. The HIF-P4H reaction is inhibited in hypoxia. HIFα evades degradation and forms a functional dimer with HIFβ, leading to activation of the HIF target genes. The central role of HIF-P4Hs in the regulation of the hypoxia response pathway has provided an attractive possibility as a drug candidate for treatment of, e.g., severe anemias and ischemic conditions, and several companies are currently carrying out clinical studies on the use of HIF-P4H inhibitors to treat anemia in patients with a kidney disease. Therefore, it is important to understand the effects of individual HIF-P4H isoenzymes on the hypoxia response and potential other pathways in vivo. The common and specific functions of the HIF-P4H isoenzymes are discussed in this review on the basis of available data from cell biological studies and gene-modified animals.


Corresponding author: Johanna Myllyharju, Oulu Center for Cell-Matrix Research, Biocenter Oulu and Department of Medical Biochemistry and Molecular Biology, University of Oulu, FIN-90014 Oulu, Finland

About the authors

Johanna Myllyharju

Johanna Myllyharju is Professor of Molecular Biology and the Scientific Director of Biocenter Oulu, University of Oulu. Her research focuses on the key enzymes involved in the regulation of collagen synthesis and hypoxia response. She is a Member of the Academy of Finland Health Sciences Council and a Member of the Management Committee of the EU COST Action TD0901 HypoxiaNet.

Peppi Koivunen

Peppi Koivunen is Professor of Medical Biochemistry in the University of Oulu, Finland. Her research focus is 2-oxoglutaratedependent dioxy genases, such as the HIF prolyl 4-hydroxylases, the HIF asparaginyl hydroxylase FIH and a novel transmembrane prolyl 4-hydroxylase, P4H-TM. Koivunen also studies the role of 2-oxoglutarate analogues in cancer, erythropoiesis, ischemia and metabolism.

Received: 2012-11-15
Accepted: 2013-1-4
Published Online: 2013-02-28
Published in Print: 2013-04-01

©2013 by Walter de Gruyter Berlin Boston

Downloaded on 15.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2012-0328/pdf
Scroll to top button